BRCA1 and BRCA2: Important differences with common interests

Nature Reviews Cancer

Volumn 12, Issue 5, 2012, Pages 372-

  Roy, Rohini ^a   Chun, Jarin ^a   Powell, Simon N ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CYTOKERATIN 17; CYTOKERATIN 5; P CADHERIN;

ALLELE; BREAST CANCER; DOWN REGULATION; FANCONI ANEMIA; GENOMIC INSTABILITY; HEREDITARY BREAST AND OVARIAN CANCER SYNDROME; HUMAN; LETTER; MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

EID: 84860199582     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc3181-c3     Document Type: Letter

References (12)

1. Roy, R., Chun, J. & Powell, S. N. BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nature Rev. Cancer 12, 68-78 (2012).
2. Yu, K.-D. & Shao, Z.-M. Initiation, evolution, phenotype and outcome of BRCA1 and BRCA2 mutation-associated breast cancer. Nature Rev. Cancer 24 Apr 2012 (doi:10.1038/nrc3181-c1).
3. Joosse, S.A. BRCA1 and BRCA2: a common pathway of genome protection but different breast cancer subtypes. Nature Rev. Cancer 24 Apr 2012 (doi:10.1038/nrc3181-c2).
4. Walsh, C. S. et al. Genome-wide loss of heterozygosity and uniparental disomy in BRCA1/2-associated ovarian carcinomas. Clin. Cancer Res. 14, 7645-7651 (2008).
5. King, T. A. et al. Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis. Ann. Surg. Oncol. 14, 2510-2518 (2007). (Pubitemid 47389559)
6. Spearman, A. D. et al. Clinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significance. J. Clin. Oncol. 26, 5393-5400 (2008).
7. Clarke, C. L. et al. Mapping loss of heterozygosity in normal human breast cells from BRCA1/2 carriers. Br. J. Cancer 95, 515-519 (2006). (Pubitemid 44232561)
8. Locke, I. et al. Loss of heterozygosity at the BRCA1 and BRCA2 loci detected in ductal lavage fluid from BRCA gene mutation carriers and controls. Cancer Epidemiol. Biomarkers Prev. 15, 1399-1402 (2006). (Pubitemid 44125300)
9. Brozek, I. et al. Loss of heterozygosity at BRCA1/2 loci in hereditary and sporadic ovarian cancers. J. Appl. Genet. 50, 379-384 (2009).
10. Vogelstein, B. & Kinzler, K. W. Cancer genes and the pathways they control. Nature Med. 10, 789-799 (2004). (Pubitemid 39070849)
11. Parmigiani, G. et al. Design and analysis issues in genome-wide somatic mutation studies of cancer. Genomics. 93, 17-21 (2009).
12. Joosse, S. A. et al. Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH. Breast Cancer Res. Treat. 116, 479-489 (2009).